Alvotech
ALVO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001898416
No open-market purchases or sales by Alvotech insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $157.4M in total; Oaktree Capital is the only superinvestor holding it.
Other share classesALVOW
Q3 2025 vs. Q2 2025
How the institutions holding Alvotech changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 53 | 1 | 66 | +14 |
| Shares | 17.3M | 180.0K | 15.8M | −1.25M (−7.3%) |
| Value | $156.0M | $1.66M | $127.9M | −$26.5M (−17.2%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Alvotech at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 136,859 | $1.12M | 0.00% |
| Citadel Advisors LLC | 42,202 | $345.6K | 0.00% |
| Renaissance Technologies LLC | 32,166 | $263.4K | 0.00% |
| XTX Topco Ltd | 27,246 | $223.1K | 0.01% |
| Quadrature Capital Ltd | 22,729 | $185.9K | 0.00% |
| GWN Securities Inc. | 19,591 | $160.5K | 0.04% |
| Brinker Capital Investments, LLC | 11,270 | $92.3K | 0.00% |
| Ulland Investment Advisors, LLC | 11,250 | $92.0K | 0.07% |
| ProShare Advisors LLC | 11,151 | $91.3K | 0.00% |
| Magnetar Financial LLC | 10,462 | $85.7K | 0.00% |
| State of Wyoming | 6,606 | $54.1K | 0.01% |
| Steward Partners Investment Advisory, LLC | 1,715 | $14.0K | 0.00% |
| Rialto Wealth Management, LLC | 600 | $4.91K | 0.00% |
| Farther Finance Advisors, LLC | 273 | $2.24K | 0.00% |
| GAMMA Investing LLC | 225 | $1.84K | 0.00% |
| Allworth Financial LP | 150 | $1.23K | 0.00% |
| SWAN Capital LLC | 100 | $819 | 0.00% |
| Bare Financial Services, Inc | 62 | $508 | 0.00% |
| North Star Investment Management Corp. | 56 | $459 | 0.00% |
| SBI Securities Co., Ltd. | 1 | $8 | 0.00% |
Sold out (6)
Institutions that held Alvotech at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Heights Capital Management, Inc | 1,090,664 | $9.95M |
| Gilder Gagnon Howe & Co LLC | 195,345 | $1.78M |
| Exome Asset Management LLC | 78,372 | $714.8K |
| Balyasny Asset Management LLC | 14,134 | $128.9K |
| Vident Advisory, LLC | 10,762 | $98.1K |
| Caitong International Asset Management Co., Ltd | 507 | $4.62K |
Not filed for Q3 2025 yet (1)
Institutions that held Alvotech at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Norges Bank | 180,000 | $1.66M |